Drug Type Small molecule drug |
Synonyms SND-5, SND-51 |
Target |
Mechanism DAAO inhibitors(D-amino-acid oxidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psychotic Disorders | Phase 2 | US | 29 Nov 2019 | |
Psychotic Disorders | Phase 2 | CN | 29 Nov 2019 | |
Psychotic Disorders | Phase 2 | CA | 29 Nov 2019 | |
Psychotic Disorders | Phase 2 | - | 29 Nov 2019 | |
Psychotic Disorders | Phase 2 | TW | 29 Nov 2019 | |
Alzheimer Disease | Phase 2 | US | - |